SOPH - SOPHIA GENETICS SA
This page shows which of the focused investors we track hold SOPH and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2025 it was held by 2 managers with an aggregate reported value of $17.47M, which is 0.00% of the combined portfolio.
As of Q4 2025, 2 tracked institutional managers held SOPH (SOPHIA GENETICS SA) with an aggregate reported value of $17.47M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SOPH — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2025
- Ticker
- SOPH
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Chuck Akre - Akre Capital Management | 0.19% | - | 3,719,140 | $17.37M |
| 2 | Polen Capital Management - Polen Capital Management | 0.00% | New | 21,738 | $101.52K |
Loading holder history for SOPH…